Global Drug Facility releases roadmap for scale-up of MDR-TB treatment
22 November 2010 - Geneva - The Global Drug Facility (GDF) today released a white paper setting forth its plans to facilitate scaled up access to MDR-TB treatment. The "Roadmap for MDR-TB Scale-up: Increasing Access to MDR-TB Drugs through Innovation and Action" outlines progress GDF has made to date, identifies what is still needed and where high-level advocacy could assist GDF to further scale up its activities.
GDF has nearly tripled the number of countries to which it supplies quality- assured MDR-TB medicines over the past three years - reaching 54 countries in 2010, up from 19 in 2007. GDF will continue to ensure that future demand for drugs is met and a sustainable market is created.
GDF is engaging in key innovative approaches to render the market more attractive to suppliers, including a tiered market allocation system, improved forecasting, a rotating stockpile and an advanced financing mechanism.
In This Section
News writers:
Sam Nuttall
Vittorio Cammarota
Young-Ae Chu
Jenniffer Dietrich
Elisabetta Minelli